• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-1271 通过靶向 IRS1 并使 AKT 通路失活抑制甲状腺乳头状癌的进展。

MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.

机构信息

Department of Breast, Thyroid Surgery, Research Institute of Surgery, Daping Hospital, Army Military Medical University, Chongqing, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7989-7999. doi: 10.26355/eurrev_201909_19015.

DOI:10.26355/eurrev_201909_19015
PMID:31599424
Abstract

OBJECTIVE

The important role of microRNA-1271 (miR-1271) has been identified in human diseases and cancers. However, the biological function of miR-1271 remains ambiguous in papillary thyroid carcinoma (PTC). Therefore, the specific role of miR-1271 was investigated in PTC.

PATIENTS AND METHODS

The expressions of miR-1271 and insulin receptor substrate 1 (IRS1) were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) assay. The protein expression of the genes was measured by Western blot analysis. The function of miR-1271 was investigated using methyl thiazolyl tetrazolium (MTT) and transwell assays. The Dual-Luciferase assay was used to observe the relationship between miR-1271 and IRS1.

RESULTS

MiR-1271 was downregulated in PTC tissues. Moreover, overexpression of miR-1271 suppressed migration, invasion and proliferation of PTC cells. Furthermore, IRS1 was indicated as a direct target gene of miR-1271 and knockdown of IRS1 inhibited cell migration, invasion and proliferation in PTC. In addition, miR-1271 inhibited the progression of PTC by targeting IRS1. Besides that, miR-1271 blocked the epithelial-mesenchymal transition (EMT) and protein kinase B (AKT) pathway in PTC.

CONCLUSIONS

MiR-1271 inhibited the progression of PTC by targeting IRS1 and blocking EMT and AKT pathway.

摘要

目的

微小 RNA-1271(miR-1271)在人类疾病和癌症中的重要作用已得到证实。然而,miR-1271 在甲状腺乳头状癌(PTC)中的生物学功能仍不明确。因此,本研究旨在探讨 miR-1271 在 PTC 中的具体作用。

患者与方法

通过实时定量聚合酶链反应(qRT-PCR)检测 miR-1271 和胰岛素受体底物 1(IRS1)的表达。通过 Western blot 分析测量基因的蛋白表达。使用甲基噻唑基四唑(MTT)和 Transwell 测定法研究 miR-1271 的功能。双荧光素酶报告基因实验观察 miR-1271 与 IRS1 之间的关系。

结果

miR-1271 在 PTC 组织中表达下调。此外,过表达 miR-1271 抑制 PTC 细胞的迁移、侵袭和增殖。进一步研究表明,IRS1 是 miR-1271 的直接靶基因,敲低 IRS1 抑制 PTC 细胞的迁移、侵袭和增殖。此外,miR-1271 通过靶向 IRS1 抑制 PTC 的进展。除此之外,miR-1271 阻断了 PTC 中的上皮间质转化(EMT)和蛋白激酶 B(AKT)通路。

结论

miR-1271 通过靶向 IRS1 并阻断 EMT 和 AKT 通路抑制 PTC 的进展。

相似文献

1
MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway.微小 RNA-1271 通过靶向 IRS1 并使 AKT 通路失活抑制甲状腺乳头状癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7989-7999. doi: 10.26355/eurrev_201909_19015.
2
MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.MicroRNA-31 通过直接靶向 SOX11 并调节上皮间质转化、ERK 和 Akt 信号通路抑制甲状腺乳头状癌细胞的生物学进展。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5863-5873. doi: 10.26355/eurrev_201907_18329.
3
MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.微小 RNA-26a 通过靶向 ROCK1 并调控 PI3K/AKT 信号通路抑制甲状腺乳头状癌细胞的恶性生物学行为。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8940-8949. doi: 10.26355/eurrev_201910_19292.
4
MicroRNA-486 inhibits cell proliferation, invasion and migration via down-regulating the TENM1 expressions and affecting ERK and Akt signaling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma.微小 RNA-486 通过下调 TENM1 的表达,影响 ERK 和 Akt 信号通路以及甲状腺乳头状癌的上皮间质转化,抑制细胞增殖、侵袭和迁移。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8429-8439. doi: 10.26355/eurrev_201910_19155.
5
MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3.MicroRNA-203 通过下调 AKT3 抑制甲状腺乳头状癌细胞的上皮-间充质转化、侵袭和迁移。
Cell Cycle. 2020 May;19(10):1105-1121. doi: 10.1080/15384101.2020.1746490. Epub 2020 Apr 19.
6
miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.miR-215 通过靶向 ARFGEF1 抑制 AKT/GSK-3β/Snail 信号通路抑制甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Cell Death Dis. 2019 Feb 27;10(3):195. doi: 10.1038/s41419-019-1444-1.
7
miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.miRNA-21 通过 VHL/PI3K/AKT 促进甲状腺乳头状癌的细胞增殖和侵袭。
Hum Cell. 2019 Oct;32(4):428-436. doi: 10.1007/s13577-019-00254-4. Epub 2019 Jun 3.
8
microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.microRNA-539 通过靶向分泌白细胞蛋白酶抑制剂在甲状腺乳头状癌中作为肿瘤抑制因子通过转化生长因子β1/Smads 信号通路发挥作用。
J Cell Biochem. 2019 Jun;120(6):10830-10846. doi: 10.1002/jcb.28374. Epub 2019 Jan 31.
9
MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.微小RNA-766通过直接靶向胰岛素受体底物2并调节PI3K/Akt信号通路来抑制甲状腺乳头状癌的进展。
Int J Oncol. 2019 Jan;54(1):315-325. doi: 10.3892/ijo.2018.4615. Epub 2018 Nov 1.
10
MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.miR-192-5p 通过调控 SH3RF3 抑制甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Biosci Rep. 2021 Sep 30;41(9). doi: 10.1042/BSR20210342.

引用本文的文献

1
The regulatory network of epithelial-mesenchymal transition-associated non-coding RNAs in thyroid cancer: molecular mechanisms, clinical implications, and therapeutic strategies.甲状腺癌中上皮-间质转化相关非编码RNA的调控网络:分子机制、临床意义及治疗策略
Front Oncol. 2025 Jun 2;15:1592467. doi: 10.3389/fonc.2025.1592467. eCollection 2025.
2
The regulation of LRPs by miRNAs in cancer: influencing cancer characteristics and responses to treatment.微小RNA在癌症中对低密度脂蛋白受体相关蛋白的调控:影响癌症特征及对治疗的反应
Cancer Cell Int. 2025 May 17;25(1):182. doi: 10.1186/s12935-025-03804-z.
3
Circ_0011373 promotes papillary thyroid carcinoma progression by regulating miR-1271/LRP6 axis.
环状 RNA 0011373 通过调控 miR-1271/LRP6 轴促进甲状腺乳头状癌细胞的进展。
Hormones (Athens). 2023 Sep;22(3):375-387. doi: 10.1007/s42000-023-00461-7. Epub 2023 Jun 28.
4
Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer.微小RNA在甲状腺乳头状癌中的表达谱及诊断意义
Cancers (Basel). 2022 May 28;14(11):2679. doi: 10.3390/cancers14112679.
5
MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020.甲状腺乳头状癌中的微小RNA:2018年至2020年6月的系统评价
Cancers (Basel). 2020 Oct 25;12(11):3118. doi: 10.3390/cancers12113118.
6
microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway.miRNA-1271-5p/TIAM1 通过抑制 Notch 信号通路抑制卵巢癌的进展。
J Ovarian Res. 2020 Sep 18;13(1):110. doi: 10.1186/s13048-020-00720-w.
7
The Prognostic Value of MicroRNAs in Thyroid Cancers-A Systematic Review and Meta-Analysis.微小RNA在甲状腺癌中的预后价值——一项系统评价和荟萃分析
Cancers (Basel). 2020 Sep 12;12(9):2608. doi: 10.3390/cancers12092608.